NCT04000737 2025-04-13
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Yiviva Inc.
Phase 2 Completed
Clinical Trials
22 trialsNCT04710641 2025-03-06
OUTREACH2
Mina Alpha Limited
Phase 2 Completed
NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00059267 2024-11-15
Prevention of Recurrent Hepatitis B After Liver Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed
NCT06629857 2024-10-08
A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan
Darul Sehat Hospital
Completed
NCT01350648 2024-10-01
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
National Institutes of Health Clinical Center (CC)
Completed
NCT05823584 2024-04-10
Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence
TCM Biotech International Corp.
Completed
NCT02366286 2023-12-14
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Completed
NCT03702998 2023-08-30
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
Completed
NCT05406089 2022-06-21
Effects of Antiviral Therapy on Patients With HBV-related HCC
First Affiliated Hospital Xi'an Jiaotong University
Completed
NCT04659005 2022-04-06
Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening
Chinese University of Hong Kong
Phase NA Completed
NCT02785835 2022-03-16
GEHEP-002
Hospital Universitario de Valme
Completed
NCT00888407 2017-05-30
Community-based Hepatitis B Interventions for Hmong Adults
University of California, Davis
Phase NA Completed
NCT00322361 2017-03-16
Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT01790633 2016-12-13
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase NA Completed
NCT00824707 2016-04-01
Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT00834158 2016-04-01
TACEPVE
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT02025842 2014-01-01
HBV/HCC
Azienda Ospedaliera San Camillo Forlanini
Completed
NCT01022476 2013-07-18
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2 Completed
NCT00629486 2013-04-18
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase NA Completed
NCT00769730 2009-08-04
Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication
Kaohsiung Medical University Chung-Ho Memorial Hospital
Completed
NCT00222664 2005-09-22
Qidong Hepatitis B Intervention Study
University of Oxford
Phase 4 Completed